Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Stem Cell Mobilization Chemotherapy with Gemcitabine Is Effective and Safe in Myeloma Patients with Bortezomib Induced Neurotoxicity

Beatrice U. Mueller, MD, Sandra Keller, MD, Katja Seipel, PhD, Behrouz Mansouri Taleghani, MD, Thomas Pabst, MD

Blood (2015) 126 (23): 5436.

https://doi.org/10.1182/blood.V126.23.5436.5436

Published: 2015

Journal Articles

The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients

Sarah Mans, Yara Banz, Beatrice U. Mueller, Thomas Pabst

Blood (2012) 120 (13): 2690–2699.

https://doi.org/10.1182/blood-2012-02-412759

Published: 2012

Includes: Supplemental data

Journal Articles

Anthracycline Treatment Induces Extracellular Calreticulin in Acute Myeloid Leukemia

Sarah Mans, Kerstin Schaubitzer, PhD, Deborah Shan, Beatrice U Mueller, Thomas Pabst, MD

Blood (2011) 118 (21): 1376.

https://doi.org/10.1182/blood.V118.21.1376.1376

Published: 2011

Journal Articles

Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML

Simon Haefliger, Christiane Klebig, Kerstin Schaubitzer, Julian Schardt, Nikolai Timchenko, Beatrice U. Mueller, Thomas Pabst

Blood (2011) 117 (22): 5931–5940.

https://doi.org/10.1182/blood-2010-08-304485

Published: 2011

Includes: Supplemental data

Journal Articles

Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis

José Fos, Thomas Pabst, Vibor Petkovic, Daniel Ratschiller, Beatrice U. Mueller

Blood (2011) 117 (18): 4881–4884.

https://doi.org/10.1182/blood-2010-11-320747

Published: 2011

Includes: Supplemental data

Journal Articles

Heterozygous deletion of the PU.1 locus in human AML

Nicola Bonadies, Thomas Pabst, Beatrice U. Mueller

Blood (2010) 115 (2): 331–334.

https://doi.org/10.1182/blood-2009-03-212225

Published: 2010

Includes: Supplemental data

Journal Articles

The Unfolded Protein Response (UPR) Is Activated in Human Acute Myeloid Leukemia (AML) and Suppresses Translation of the CCAAT/Enhancer Binding Protein-Alpha (CEBPA) by Induction of the RNA-Binding Protein Calreticulin

Julian Schardt, MD, Marianne Eyholzer, Beatrice U Mueller, Thomas Pabst, MD

Blood (2008) 112 (11): 2934.

https://doi.org/10.1182/blood.V112.11.2934.2934

Published: 2008

Journal Articles

Suppressed CEBPA Function Is Associated with Favorable Prognosis in Normal Karyotype AML Patients

Jose Fos, Nicola Bonadies, Thomas Pabst, Beatrice U Mueller

Blood (2008) 112 (11): 2506.

https://doi.org/10.1182/blood.V112.11.2506.2506

Published: 2008

Journal Articles

Activation of the Unfolded Protein Response (UPR) Induces CEBPA mRNA Decay in AML Cells.

Marianne Eyholzer, Julian Schardt, Deborah Shan, Beatrice U Mueller, Thomas Pabst

Blood (2008) 112 (11): 2258.

https://doi.org/10.1182/blood.V112.11.2258.2258

Published: 2008

Journal Articles

ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression

Beatrice U. Mueller, Thomas Pabst, José Fos, Vibor Petkovic, Martin F. Fey, Norio Asou, Ulrich Buergi, Daniel G. Tenen

Blood (2006) 107 (8): 3330–3338.

https://doi.org/10.1182/blood-2005-07-3068

Published: 2006

Includes: Supplemental data

Journal Articles

Enhancing Neutrophil Differentiation - A Novel Role for the Death-Associated Protein Kinase 2 (DAPK2).

Mattia Rizzi, MD, Christian Britschgi, MD, Mario P. Tschan, PhD, Tobias J. Grob, MD, PhD, Barbara Huegli, Nicolas Leupin, MD, Beatrice U. Mueller, MD, Andrew Ziemiecki, PhD, Bruce E. Torbett, PhD, Martin F. Fey, MD, Andreas Tobler, MD

Blood (2005) 106 (11): 1348.

https://doi.org/10.1182/blood.V106.11.1348.1348

Published: 2005

Journal Articles

CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)

Daniel Helbling, Beatrice U. Mueller, Nikolai A. Timchenko, Julian Schardt, Myriam Eyer, David R. Betts, Martine Jotterand, Sandrine Meyer-Monard, Martin F. Fey, Thomas Pabst

Blood (2005) 106 (4): 1369–1375.

https://doi.org/10.1182/blood-2004-11-4392

Published: 2005

Journal Articles

Inv (16) Suppresses CEBPA in Acute Myeloid Leukemia by Activation of Calreticulin.

Daniel Helbling, Beatrice U. Mueller, Nikolai A. Timchenko, David R. Betts, Martine Jotterand, Sandrine Meyer-Monard, Martin F. Fey, Thomas Pabst

Blood (2004) 104 (11): 3388.

https://doi.org/10.1182/blood.V104.11.3388.3388

Published: 2004

Journal Articles

ATRA Resolves the Differentiation Block in t(15;17) Myeloid Leukemia by Restoring PU.1 Expression.

Beatrice U. Mueller, MD, Thomas Pabst, MD, Motomi Osato, MD, Daniel G. Tenen, MD

Blood (2004) 104 (11): 389.

https://doi.org/10.1182/blood.V104.11.389.389

Published: 2004

Journal Articles

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

Beatrice U. Mueller, Thomas Pabst, Motomi Osato, Norio Asou, Lisa M. Johansen, Mark D. Minden, Gerhard Behre, Wolfgang Hiddemann, Yoshiaki Ito, Daniel G. Tenen

Blood (2003) 101 (5): 2074.

https://doi.org/10.1182/blood-2002-12-3903

Published: 2003

Journal Articles

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

Beatrice U. Mueller, Thomas Pabst, Motomi Osato, Norio Asou, Lisa M. Johansen, Mark D. Minden, Gerhard Behre, Wolfgang Hiddemann, Yoshiaki Ito, Daniel G. Tenen

Blood (2002) 100 (3): 998–1007.

https://doi.org/10.1182/blood.V100.3.998

Published: 2002

Journal Articles

PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding

Pu Zhang, Xiaobo Zhang, Atsushi Iwama, Channing Yu, Kent A. Smith, Beatrice U. Mueller, Salaija Narravula, Bruce E. Torbett, Stuart H. Orkin, Daniel G. Tenen

Blood (2000) 96 (8): 2641–2648.

https://doi.org/10.1182/blood.V96.8.2641

Published: 2000

NARROW

Stem Cell Mobilization Chemotherapy with Gemcitabine Is Effective and Safe in Myeloma Patients with Bortezomib Induced Neurotoxicity

The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients

Anthracycline Treatment Induces Extracellular Calreticulin in Acute Myeloid Leukemia

Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML

Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis

Heterozygous deletion of the PU.1 locus in human AML

The Unfolded Protein Response (UPR) Is Activated in Human Acute Myeloid Leukemia (AML) and Suppresses Translation of the CCAAT/Enhancer Binding Protein-Alpha (CEBPA) by Induction of the RNA-Binding Protein Calreticulin

Suppressed CEBPA Function Is Associated with Favorable Prognosis in Normal Karyotype AML Patients

Activation of the Unfolded Protein Response (UPR) Induces CEBPA mRNA Decay in AML Cells.

ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression

Enhancing Neutrophil Differentiation - A Novel Role for the Death-Associated Protein Kinase 2 (DAPK2).

CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)

Inv (16) Suppresses CEBPA in Acute Myeloid Leukemia by Activation of Calreticulin.

ATRA Resolves the Differentiation Block in t(15;17) Myeloid Leukemia by Restoring PU.1 Expression.

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only